Status:
COMPLETED
A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)
Lead Sponsor:
Allergan
Conditions:
Macular Edema
Eligibility:
All Genders
18+ years
Brief Summary
This study will use retrospective data to evaluate the efficacy, safety, and re-injection interval of OZURDEX® in the treatment of macular oedema due to Retinal Vein Occlusion (RVO).
Eligibility Criteria
Inclusion
- Macular oedema in the study eye due to BRVO or CRVO
- Received at least 2 OZURDEX® injections in the study eye
Exclusion
- Received OZURDEX® injections as part of or during any clinical study
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT01445626
Start Date
October 1 2011
End Date
January 1 2012
Last Update
February 18 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Münster, Germany